05/28/2020 | Press Release
Dr. Linda Kidder will focus on key life science markets and applications
HORIBA Scientific, a global leader in Raman, fluorescence spectroscopy and particle characterization solutions, is pleased announce that Dr. Linda Kidder has joined the company as our new Life Sciences Business Development Manager. Dr. Kidder will focus on developing and expanding our suite of scientific instruments to meet the requirements of selected key life science markets and applications.
Dr. Kidder will collaborate with key opinion leaders and scientists across a number of life science industries to provide market requirements to the product development teams at HORIBA. She will also collaborate with the other HORIBA segments, including the HORIBA Medical and HORIBA Process and Environmental segments, to leverage their expertise and enable key joint product developments.
Prior to joining HORIBA, Linda co-founded Spectral Dimensions, who provided spectroscopic imaging solutions to the pharmaceutical industry. It was acquired by Malvern Instruments, where she became Global Project Manager of Chemical Imaging. She then joined their Bioscience Development Initiative as Senior Scientist. Looking to expand her business development role, she moved to BrightSpec, a startup specializing in chiral analysis, and then to Shimadzu as Strategic Product Leader, responsible for their 13 analytical instrumentation product lines in North America.
“We are thrilled to have Linda join our team to help us develop our life science applications and instrument capabilities,” said Dr. Andrew Whitley, VP Sales and Business Development for HORIBA Scientific. “Linda will be a fantastic resource for our customers and colleagues to ensure that their requirements are met in our analytical instrument solutions for life sciences.”
About HORIBA Scientific
HORIBA Scientific, part of HORIBA Instruments Incorporated, headquartered in the United States, provides an extensive array of instruments and solutions for applications across a broad range of scientific R&D and QC measurements. HORIBA Scientific is a world leader in OEM Spectroscopy, elemental analysis, fluorescence (including the PTI brand), forensics, GDS, ICP, particle characterization, Raman, spectroscopic ellipsometry, sulfur-in-oil, SPRi and water quality measurements, as well as XRF. Our instruments are found in universities and industries around the world. Proven quality and trusted performance have established widespread confidence in the HORIBA Brand.
HORIBA supplies over 500 types of scientific analyzers to universities, research institutions, various manufacturing industries and the government. In some of the most advanced science and technologies, HORIBA provides multi-faceted data solutions for what are niche markets – assisting the most cutting-edge research in the tackling of uncharted territories.
Building on a long tradition of pursuing innovative technology to advance scientific efforts, HORIBA Instruments Incorporated has acquired and assimilated renowned companies such as Société Générale d’Optique (1969), SPEX (1988), Dilor (1995), SOFIE (1996), Jobin Yvon (1997), IBH (2003), GenOptics (2009), and Photon Technology International (2014).
The HORIBA Group is a global company that offers solutions and engineering services, based on our strong performance in developing and manufacturing instruments and products in the analysis and measurement fields. With “Explore the Future” as its brand message, HORIBA has been pursuing state-of-the-art analysis and measurement technology since its establishment in 1945. Founded in the historic city of Kyoto, Japan, it has grown steadily throughout its 75 years of business and is now providing services worldwide as the leader in the analysis technology field.
We engage in five different business segments with high value-added products and services: Automotive Test Systems, Medical-Diagnostic Instruments and Systems, Semiconductor Instruments and Systems, Scientific Instruments and Systems, and Process and Environmental Instruments and Systems. We have established an optimal number of business bases in Japan, Asia, Europe, and the Americas.